About the Company

Wuhan Jingchuan Diagnostic Technology Co., Ltd. was founded in 2006 and is a specialized high-tech enterprise integrating the research and development, production, and sales of in vitro diagnostic analytical instruments and in vitro diagnostic reagents. Relying on independent technology and its R&D team, the company has obtained nearly 40 independent intellectual property rights, patented technologies, and 43 medical device product registration certificates, covering two major fields: hematology and body fluid diagnostics, and biochemical diagnostics. The company has a registered capital of 34 million yuan and was officially listed on the New Third Board on January 22, 2015, with the securities abbreviation: Jingchuan Diagnostics, and stock code: 831676. Seizing industry opportunities and relying on advantageous resources, combined with its existing comprehensive strengths, the company has rapidly formed a stable marketing network with Wuhan as its production base and sales and service coverage across the country, with sales growth exceeding 30% for several consecutive years. The company has been awarded the title of "Gazelle Enterprise" for six consecutive years and has been recognized as a "High-tech Enterprise" multiple times. The company adheres to the employment philosophy of "people-oriented, comprehensive development," and is committed to providing a career platform that allows employees to fully utilize their talents and achieve personal careers, creating opportunities for employees to realize a better life and their own value. Jingchuan Diagnostics Corporate Culture Corporate Vision: To become an excellent supplier of medical device products and services Corporate Spirit: Innovation, Efficiency, Pragmatism, Integrity Core Values: Customer Orientation, Proactive Efficiency, Continuous Innovation, Pursuit of Excellence, Win-Win Cooperation Corporate Mission: To develop the medical laboratory cause and serve public health Join Jingchuan Diagnostics, and you will receive: Open compensation system: competitive salary, five insurances and one housing fund, seniority pay, annual outstanding evaluation and selection Systematic training mechanisms: cultural training, job skills training, management training, team building, external training Comprehensive promotion mechanism: comprehensive human resources growth mechanism, broad development platform Comprehensive welfare protection: two-day weekends, statutory holidays, paid annual leave and other paid leave Various living allowances: meal allowance, housing allowance, transportation allowance, communication allowance, holiday condolences, etc.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

摘牌景川 Financing History (1 rounds)

Manage
新三板
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 新三板
  • Deal: 全国股转系统

摘牌景川 Recruitment Overview / Current Status (4 open positions)

Manage
Note: How fast is hiring at Wuhan Jingchuan Diagnostic Technology Co., Ltd. growing? . A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

摘牌景川 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

摘牌景川 Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 3,793万(元)
Legal Representative: 马全新
Date Established:
Credit Code: 91420100783160245E
Registered Address: 武汉市东湖新技术开发区高新二路388号武汉光谷国际生物医药企业加速器1.1期6号楼

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates